Agoracom Blog Home

Posts Tagged ‘Hemp’

Bougainville Ventures Inc $BOG.ca – Canada’s chronic shortage of legal cannabis expected to drag out for years $CROP.ca $VP.ca NF.ca $MCOA

Posted by AGORACOM-JC at 12:19 PM on Tuesday, January 29th, 2019
SPONSOR:  Bougainville Ventures Inc (CSE: BOG) Converting irrigated farmland to greenhouse-equipped farmland. Bougainville does not “touch the plant” and only provides agricultural infrastructure as a landlord for licensed marijuana growers. Click here for more info.
BOG:CSE
—————————————

Canada’s chronic shortage of legal cannabis expected to drag out for years

One industry insider expects shortage to continue until 2022, as more legal cannabis diverted to edibles

Canada’s licensed producers are growing more cannabis than ever. But they still aren’t making enough to balance supply and demand. (Derek Hooper/CBC)

Canada’s persistent shortage of legal cannabis could drag on for years. The impending legalization of edible pot will only divert more product away from empty store shelves across the country. One industry insider said he now expects that shortage to endure until 2022.

“If it was just the current product set, I’d say a year to 18 months,” said Chuck Rifici, CEO of the Toronto-based cannabis company Auxly.

“But because we have edibles and a bunch of new product types coming in October, I think it’ll be the better part of three years before we have true equilibrium and oversupply in the space.”

Licensed producers have been adding capacity in droves. Millions of square feet of new greenhouse space has been built since last summer. But for every new gram produced, new demand is piling up as well.

“The medical cannabis market still grows by about five per cent a month,” said Rifici. “We have about 300,000 Canadians accessing medically, so that’s a drain on the system, as well as international exports that are starting to amplify.”

Edibles industry ramps up

Meanwhile, the edible cannabis side of the industry is only starting to ramp up. The makers of Corona beer and Kim Crawford wines teamed up with Canopy Growth and expect to roll out cannabis-infused beer and wine. Budweiser partnered with Tilray, and Molson-Coors created their own joint venture with Quebec-based Hexo.

Cannabis-infused food and drink promises to open a whole new segment of the market. A recent report by Deloitte found 49 per cent of probable cannabis users in Canada are willing to try edibles. But that growth comes with a whole new batch of regulations and expectations.

It may take as many as three years before licensed producers are growing enough to supply the recreational, medicinal and edible markets. (Jeff McIntosh/Canadian Press)

Health Canada will require strict rules around shelf life and refrigeration. There will be specific rules around doses per serving. And that’s where Kevin Letun and Pacific Rim Brands hope to step in. His company has partnered with labs at the University of British Columbia in Kelowna and the British Columbia Institute of Technology to dig into the science behind all that.

“Because this is a brand new consumer product and it’s utilizing a schedule-1 drug that’s been illegal for the last 80 years, consumers are going to want to trust the brand that they’re going to be trying in the future,” said Letun.

Right now, Pacific Rim Brands is working on getting the specific formulations for these products. Once that’s completed, the company expects to start human testing to gather data. Essentially, the company is aiming to have formulations ready and approved this summer.

“Then, our goal is to look to either license these to existing beverage companies, potentially licensed producers or even develop our own brands,” said Letun.

When the legal recreational market opened on Oct. 17, 2018, stores like this one in NWT quickly sold out of product. (Hilary Bird/CBC)

Letun said edibles will prove to be a much larger segment of the industry than the current smokeable pot.

“In the next ten years, you’re going to see the smokeable cannabis (comprising) maybe only 10 to 20 per cent of the market,” he said.

He expects edibles and infused drinks will take off once legalized. And he said that will go well beyond cannabis-infused beer and wine.

“There are so many other applications on the medicinal side too, when it comes to sleep aids or sports recovery when it comes to inflammation, pain, sports recovery.”

Public consultations into the legalization of edible cannabis are open now and are expected to conclude at the end of February. As rules become more clear, the summer will see another surge in demand as companies look to get products ready for a market expected to open up on October 17.

It has only been three months since cannabis was legalized in Canada. There’s something to be said for the fact that the highest profile issue to stem from such an enormous change in drug policy is a lack of supply.

That issue is moving toward resolution, perhaps more slowly than expected.

Source: https://www.cbc.ca/news/business/canada-cannabis-shortage-years-1.4988195

Tetra $TBP.ca Natural Health’s Distribution Partner Expands Distribution Network for the Hemp Energy Drink

Posted by AGORACOM-JC at 8:16 AM on Monday, January 28th, 2019
  • Filed a patent application for its PPP001 drug product.
  • Tetra’s research has led to a significant discovery that has enabled the company to apply for patent protection.

ORLEANS, Ontario, Jan. 28, 2019 — Tetra Bio-Pharma Inc (“Tetra” or the “Company”) (TSX VENTURE: TBP) (OTCQB: TBPMF), a leader in cannabinoid-based drug discovery and development has announced that it filed a patent application for its PPP001 drug product. Tetra’s research has led to a significant discovery that has enabled the company to apply for patent protection.

Tetra’s research demonstrated that the class II medical device or pipe used to combust the PPP001 drug pellet generates a unique composition of medicinal ingredients. This composition is significantly different from that created when heating the drug pellet in a vaporizer. The data demonstrated that the drug produced by combustion is different from that of the vapor and may partly explain the recognized efficacy of smoked cannabis. The composition of the remaining chemicals was expected to be different between smoke and vapor. This led the Corporation to implement two separate drug development paths and allow Tetra to commence developing second generation drugs for inhalation.

The patent covers methods of fabrication and composition of matter. “This patent application, if granted, would provide Tetra with full protection of its PPP001 prescription drug product placing PPP001 in the same category as any other innovative prescription drug,” said Dr. Guy Chamberland, CEO and CSO of Tetra Bio-Pharma. “This will give Tetra a much longer period of exclusivity. We recognize the inherent value of our intellectual property and the necessity to seek appropriate patents, to the extent possible, to protect our shareholders’ investments in the Company.”

Dr. Chamberland further stated, “In addition, we are pleased to announce that Tetra Natural Health’s exclusive distribution partner, Kombucha Baby Brewing Company, has advised us that our Hemp Energy Drink will be made available in a number of additional outlets in Ontario and Quebec in the not too distant future. We are very encouraged by the reaction of the market since its introduction in Q4 2018.”

About Tetra Bio-Pharma:
Tetra Bio-Pharma (TSX-V: TBP) (OTCQB: TBPMF) is a biopharmaceutical leader in cannabinoid-based drug discovery and development with a Health Canada approved, and FDA reviewed, clinical program aimed at bringing novel prescription drugs and treatments to patients and their healthcare providers. The Company has several subsidiaries engaged in the development of an advanced and growing pipeline of Bio Pharmaceuticals, Natural Health and Veterinary Products containing cannabis and other medicinal plant-based elements. With patients at the core of what we do, Tetra Bio-Pharma is focused on providing rigorous scientific validation and safety data required for inclusion into the existing bio pharma industry by regulators, physicians and insurance companies.

For more information visit: www.tetrabiopharma.com

Source: Tetra Bio-Pharma

Forward-looking statements
Some statements in this release may contain forward-looking information. All statements, other than of historical fact, that address activities, events or developments that the Company believes, expects or anticipates will or may occur in the future (including, without limitation, statements regarding: the anticipated benefits of the Proposed Transaction for Tetra; completion and expected timing of the Proposed Transaction; whether the terms of the Proposed Transaction will be as described in this press release; whether the Proposed Transaction will be successful; the receipt of the approval of the TSXV in respect of the Proposed Transaction) are forward-looking statements. Forward-looking statements are generally identifiable by use of the words “may”, “will”, “should”, “continue”, “expect”, “anticipate”, “estimate”, “believe”, “intend”, “plan” or “project” or the negative of these words or other variations on these words or comparable terminology. Forward-looking statements are subject to a number of risks and uncertainties, many of which are beyond the Company’s ability to control or predict, that may cause the actual results of the Company to differ materially from those discussed in the forward-looking statements. Factors that could cause actual results or events to differ materially from current expectations include, among other things, without limitation, the inability of the Company to obtain sufficient financing to execute the Company’s business plan; competition; regulation and anticipated and unanticipated costs and delays, the success of the Company’s research and development strategies, the success of PPP001 and the Hemp Energy Drink, the applicability of the discoveries made therein, the successful and timely completion and uncertainties related to the regulatory process including the applications for Orphan Drug Designation, the timing of clinical trials, the timing and outcomes of regulatory or intellectual property decisions and other risks disclosed in the Company’s public disclosure record on file with the relevant securities regulatory authorities. Although the Company has attempted to identify important factors that could cause actual results or events to differ materially from those described in forward-looking statements, there may be other factors that cause results or events not to be as anticipated, estimated or intended. Readers should not place undue reliance on forward-looking statements. No definitive documentation has yet been signed by the parties and there is no certainty that such documentation will be signed. The forward-looking statements included in this news release are made as of the date of this news release and the Company does not undertake an obligation to publicly update such forward-looking statements to reflect new information, subsequent events or otherwise unless required by applicable securities legislation.

For further information, please contact Tetra Bio-Pharma Inc.
Guy Chamberland, Ph.D., 
Chief Executive Officer and Chief Scientific Officer 
514-220-9225
[email protected] 
Media Contact
Energi PR
Carol LevineStephanie Engel
514-288-8500 ext. 226416-425-9143 ext. 209
[email protected][email protected]

CLIENT FEATURE: North Bud Farms $NBUD.ca sustainable low cost, high quality cannabinoid production and procurement $ACB $WEED.ca $HIP.ca

Posted by AGORACOM-JC at 3:35 PM on Friday, January 18th, 2019

WHY NORTHBUD FARMS?

  • Canadian regulatory door for CIP (Cannabinoid Infused Products) is opening this year
    As shown in other legal jurisdictions (Colorado, Washington, Nevada, California)
  • Infused products sector has become the highest margin segment of the industry
  • Positioned to be a raw input producer for this space
  • Currently working with multiple food, beverage and science companies to provide safe standardized cannabinoid infused raw inputs for large scale GMP manufacturing of products
  • Announced Creation of “1017” Distribution and Signing of a LOI to Acquire Janey’s Cannabis Line

THE OPPORTUNITY

  • Acquired late stage ACMPR applicant GrowPros MMP from Tetra Bio-Pharma (TSXV: TBP)
  • GrowPros MMP application was submitted in November 2014 and is currently in the ‘Confirmation of Readiness’ stage.
  • Announced the amendment of its licence application to add 500K SQ. FT. of outdoor cultivation area
  • Phase 1 is located on 95 acres of agricultural farmland in Low, Québec.
  • Option exists to acquire more land if needed
  • Facility will focus on GMP (higher production grade) pharma-grade cultivation and food-grade extracted inputs

CHECK OUT OUR RECENT INTERVIEW

FULL DISCLOSURE: North Bud Farms is an advertising client of AGORA Internet Relations Corp.

North Bud Farms Inc. $NBUD.ca – Canadian cannabis industry execs warn weed shortage could last three years $ACB $WEED.ca $HIP.ca

Posted by AGORACOM-JC at 11:35 AM on Thursday, January 17th, 2019

SPONSOR: North Bud Farms Inc. (NBUD:CSE) Sustainable low cost, high quality cannabinoid production and procurement focusing on both bio-pharmaceutical development and Cannabinoid Infused Products. Click Here For More Information

——————
  • Canadian cannabis industry executives are warning that product shortages in the country could take as long as three years to alleviate. Some insiders believe that cannabis production estimates are too optimistic, according to a report from Bloomberg.

By A.J. Herrington

Canadian cannabis industry executives are warning that product shortages in the country could take as long as three years to alleviate. Some insiders believe that cannabis production estimates are too optimistic, according to a report from Bloomberg.

Since the sale and use of recreational marijuana were legalized in October, product shortages have led some cannabis retailers to reduce hours or limit purchases. In Alberta, regulators originally estimated that up to 250 cannabis stores could be operating in the province by the end of this year. But product shortages caused the province to place a moratorium on issuing licenses in November. As a result, Alberta has only 65 cannabis retailers, with 20 of those located in the city of Calgary.

Chuck Rifici, chief executive officer of Auxly Cannabis Group Inc. in Toronto, said that the challenges of expanding cannabis production have made it difficult to meet the demands of the newly legal recreational cannabis market.

“There’s a lot of execution risk, people are expanding by 10, 20 times,” Rifici said. “Personally, I think we’re at least three years out from hitting real equilibrium.”

“Ultimately any manufacturing facility growing 20 times is likely to face delays,” he added.

Greg Engel, CEO of Organigram Holdings believes that it will take “a couple years” for supply to catch up with demand. And Everett Knight, the executive vice president for strategy and investments at Valens Groworks, said it could be two to three years. He said that some cultivators do not accurately predict production losses due to issues such as mold.

“It’s harder to grow cannabis than most people think,” Knight said.

However, Raj Grover, the CEO of cannabis retailer High Tide, said that supply problems are improving“on a monthly and weekly basis.”

“Our stores in Alberta are fully stocked. They’re generating great revenue,” Grover said. “I think Ontario’s decision to just open 25 stores is too much of an overstatement, they’re overthinking this a little bit.”

Government predicts ‘sufficient supply’

Tammy Jarbeau, a spokeswoman for Health Canada said in a statement in November that some product shortages could be expected.

“As with any new industry where there is considerable consumer demand, we expect there may be periods where inventories of some products run low or, in some cases, run out,” said Jarbeau. “Health Canada remains confident that there is sufficient supply of cannabis overall to meet market demand now and into the future.”

But she added that shortages were not expected to be prolonged or widespread.

“As the overall supply chain gains experience in the Canadian marketplace, it is expected that such localized and product-specific shortages will become far fewer in number,” Jarbeau said.

Source: https://www.straight.com/cannabis/1188366/canadian-cannabis-industry-execs-warn-weed-shortage-could-last-three-years#

Bougainville Ventures Inc. $BOG.ca Announces Listing on Frankfurt Stock Exchange $CROP.ca $VP.ca NF.ca $MCOA

Posted by AGORACOM-JC at 4:16 PM on Tuesday, January 15th, 2019
  • Announced that the Company’s common shares are now listed and trading on the Frankfurt Stock Exchange under the ticker symbol “8BV.”

VANCOUVER, British Columbia, Jan. 15, 2019 — Bougainville Ventures Inc. (“Bougainville” or the “Company”) (CSE: BOG) is pleased to announce that the Company’s common shares are now listed and trading on the Frankfurt Stock Exchange (“FRA”) under the ticker symbol “8BV.” The Company’s common shares continue to be listed on the Canadian Stock Exchange (“CSE”) under the ticker symbol “BOG”. The Company is actively pursuing an OTC listing in the United States.

CEO, Andy Jagpal Comments:
“Our listing on the Frankfurt Stock Exchange is an important step forward in the Company’s future growth internationally allowing European investors to capitalize on our ongoing expansion and opportunity in the Canadian and US cannabis markets.”

About Bougainville Ventures Inc.  Bougainville provides cannabis infrastructure and seed-to-sale services to I-502 tenant-growers leasing greenhouse facilities space and providing fully built-out, turnkey solutions and ancillary services including processing, cannabis expertise and marketing and sales resources.

For more information please visit: http://bougainvilleinc.com/

On behalf of the Board of Directors 
BOUGAINVILLE VENTURES INC.

Andy Jagpal, CEO and Director

For further information, please contact Andy Jagpal at [email protected] or 1-844-734-8420.

FORWARD LOOKING STATEMENTS: This news release contains certain forward-looking statements within the meaning of Canadian securities laws. Forward-looking statements are based on estimates and assumptions made by BOG in light of its experience and perception of current and expected future developments, as well as other factors that BOG believes are appropriate in the circumstances. Many factors could cause BOG’s results, performance or achievements to differ materially from those expressed or implied by the forward looking statements, including: discrepancies between actual and estimated results from exploration and development and operating risks, dependence on early exploration stage concessions; uninsurable risks; competition; regulatory restrictions, including environmental regulatory restrictions and liability; currency fluctuations; defective title to mineral claims or property and dependence on key employees. Forward-looking statements are based on the expectations and opinions of the Company’s management on the date the statements are made. The assumptions used in the preparation of such statements, although considered reasonable at the time of preparation, may prove to be imprecise and, as such, undue reliance should not be placed on forward-looking statements. The Company expressly disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise.

No regulatory authority has approved or disapproved the information contained in this news release.

Bougainville Ventures Inc $BOG.ca – Canada’s Cannabis Laws And 5 Burning Questions For 2019 $CROP.ca $VP.ca NF.ca $MCOA

Posted by AGORACOM-JC at 10:06 AM on Tuesday, January 8th, 2019
SPONSOR:  Bougainville Ventures Inc (CSE: BOG) Converting irrigated farmland to greenhouse-equipped farmland. Bougainville does not “touch the plant” and only provides agricultural infrastructure as a landlord for licensed marijuana growers. Click here for more info.
BOG:CSE

—————————————
  • 2018 was a momentous year for cannabis advocates as Canada became the second country (after Uruguay) to legalize recreational marijuana use.
  • Canadians and cannabis companies alike eagerly awaited legalization, but the rollout hasn’t been as smooth as they would have liked.

Andre Bourque Contributor

A marijuana law breakdown by Canadian Province, and five burning industry questions for 2019.Shopify Partners

This is the initial post in what will be a five-part series on the 5 Burning Questions for Canadian Cannabis in 2019. 

2018 was a momentous year for cannabis advocates as Canada became the second country (after Uruguay) to legalize recreational marijuana use. Canadians and cannabis companies alike eagerly awaited legalization, but the rollout hasn’t been as smooth as they would have liked.

The most pressing problem facing the country’s legal weed market is the fact that, in the majority of provinces, suppliers are unable to meet demand. According to MarketWatch, the complexity of scaling up a national legal cannabis supply chain has left many retailers with just a fraction of the promised products. In many areas, the supply shortage may last well into 2019.

Some experts say the bottleneck exists in the regulatory approval by Health Canada of Licensed Processors and Cultivators. “The cultivation and processing capacity exists, but the lack of licensing is keeping that production off the shelves,” Rob McIntyre, CFO of Salvation Botanicals Ltd., told me. His Canadian extraction and formulation company recently agreed to produce cannabis products for U.S.-based Medical Marijuana, Inc. for the Canadian market.

“Health Canada has added significant resources to attempt to shorten the approval process, but the backlog is significant,” McIntyre explained. “In the coming months, we expect to see this supply shortage ease.”

A shortage of marijuana in Canada threatens to undermine one aim of legalization: to tame an illegal trade estimated at about 5.3 billion Canadian dollars annually. Angry consumers say they are returning to their illegal dealers. https://t.co/dZQogk8xGY

— New York Times World (@nytimesworld) November 7, 2018

On the opposite end of a product shortage is strong product pricing for cannabis producers and retailers. A gram of high-quality cannabis in Vancouver, Canada, for example, sold for $752 a gram in November 2018. Meanwhile, in Portland, Oregon, where an overabundance of marijuana is begging to cross state lines, you could buy an entire ounce of similar high-quality cannabis as recently as December.

These initial gains, however short-term they may be, will help Canadian cannabis companies offset their startup costs. “This will quickly help companies recoup the costs of building expensive cultivation facilities,” said Debra Borchardt, CEO of Green Market Report, and Canadian cannabis industry expert. “Once production begins to meet demand, then the prices will fall, which is great for consumers, but will come at a cost to the producers.”

Another less obvious issue is the diversity of cannabis regulations from province-to-province. Though weed is legal everywhere in Canada, for smokers and businesses, where you are in the country will have a huge impact.

Currently, the only constants from province-to-province under the federal Cannabis Act are a possession limit of up to 30g of dried flower (or an equivalent) and a ban on consumption in vehicles. Beyond that, everything from the legal age to the rules on public consumption can be different—though the provinces all share a common goal in discouraging underage use and exposure.

Nationwide, the biggest change in 2019 is the legalization of edible sales, which will occur no later than October 17, 2019—one year after marijuana legalization. Since edibles are more appealing to children, Canadian officials are being much more circumspect about rolling these products out. As Vice points out, it is unclear how the regulations around edibles will play out, since the government hasn’t ruled exactly what it means for a product not to “appeal” to a young person.

Provincial Laws

Here’s a quick breakdown of the current laws in each province, plus news on any upcoming changes in 2019:

.@liftandco produced an easy-to-digest graphic of the new Canadian marijuana laws and retailers by province. The country’s outlets include both the government and private sectors. pic.twitter.com/CDbHa6aArJ

— Andre F Bourque ♕ (@SocialMktgFella) January 8, 2019

Alberta:

You must be 18 years old to consume, buy, possess, and grow. Public consumption laws are the same as tobacco, though you can’t smoke near children. Home cultivation is allowed (up to four plants).

Though the province originally planned for 250 licensed retail stores managed by Alberta Gaming, Liquor, and Cannabis, supply constraints mean it will be 6-18 months before the next stores open after the first 65 opened. The province also allows online sales controlled by the government.

British Columbia:

You must be 19 years old to consume, buy, possess, and grow. Public consumption laws are the same as tobacco, though you can’t smoke near children. Home cultivation is allowed (up to four plants), though they must be hidden from street view.

British Columbia has not put a cap on the number of retail locations, but the licensing process has been slow. The first store opened up in December in Vancouver. Like Alberta, British Columbia allows online sales controlled by the government.

Manitoba:

You must be 19 years old consume, buy, and possess. Public consumption is almost completely restricted. Unlike other provinces, you won’t be able to grow your own weed at home.

By the end of November 2018, only fourteen retailers had been granted licenses. The province will allow for private online and retail stores.

In 2019, the Safe and Responsible Retailing of Cannabis Act will take effect, adding on a 6 percent tax on revenues of licensed cannabis retailers as a “Social Responsibility Fee.”

New Brunswick:

You must be 19 to consume, buy, possess, and grow. You will only be allowed to consume it in a private residence. Up to four household plants are allowed, as long as they are locked and secured.

The province will have 20 government-run locations and permit government-controlled online sales. Like many other provinces, New Brunswick has seen a spate of store shutdowns due to a lack of supply.

Newfoundland and Labrador:

You must be 19 to consume, buy, possess, and grow. You will only be allowed to consume it in a private residence. You can grow up to four plants per household.

Newfoundland and Labrador have a hybrid retail model, with private retailers receiving licenses to sell products controlled by the Newfoundland and Labrador Liquor Corporation. Online sales will go through the government-controlled NLC as well.

Nova Scotia:

You must be 19 to consume, buy, possess, and grow. You will only be allowed to consume it in designated public places. You can grow up to four plants per household, as long as they’re inside.

Nova Scotia Liquor Corporation, a government-run entity, will control online and retail stores, with 12 physical locations available at launch. Similar to other provinces, Nova Scotia faced shortages throughout 2018.

Ontario:

You must be 19 years old to consume to buy, use, posses, and grow. Public consumption laws are the same as tobacco in the province, meaning many public areas—especially ones where children may be—are off limits. There’s a four plant limit per household.

On April 1, 2019, Ontario will begin allowing private retail stores, but for now the only place to get it is through retail and online stores—the aptly names Ontario Cannabis Store—controlled by the Ontario LCBO. Thus far, the rollout has been…buggy. A questionable supply chain has been plagued by mold, mislabeled products, and mites, leading many to return to the black market in the region.

Prince Edward Island:

You must be 19 to consume, buy, possess, and grow. You will only be allowed to consume it in private residences at present. You can grow up to four plants per household, as long as they’re inside and not in reach of children.

Like many other provinces, a government-run entity, the Prince Edward Island Cannabis Management Corporation, will operate retail locations and online sales. At launch, there were four licensed retail locations. Compared to other areas, PEI’s rollout has been relatively smooth.

Quebec:

You must be 18 years old to consume, buy, and possess. Public consumption follows the same rules as tobacco, with smoking at schools and universities expressly prohibited. That may all change if newly proposed laws pass in 2019 which would raise the legal age to 21 and prohibit any smoking in public. Regardless, you cannot grow plants at home.

All online and retail sales are controlled by the Société Québécoise du Cannabis (SQDC). Since pot was legalized in October, retail locations have been closed several days of the week because of the lack of supply.

Saskatchewan:

You must be 19 years old to consume, buy, possess, and grow. Public consumption is prohibited. Four household plants are allowed per household.

Unlike many other provinces, Saskatchewan will have a private distribution system. The province handed out 51 licenses prior to Oct. 17, the day sales became legal, but as of December only a handful of those stores have opened because of supply issues. Online sales are allowed through private retailers.

5 Burning Questions for 2019

2019 marks the first full year of legal cannabis in Canada. 2018 was full of excitement for legalization, plus a whole bunch of disappointment as supply issues affected many parts of the country.

As we head into the new year, these are the biggest questions Canada’s cannabis industry will need to answer.

  1. Will There Be Enough (Legal) Pot in Canada?

It would be an understatement to say that cannabis consumers were not best of buds with the country’s suppliers.

  1. What Trends Will Dominate?

For consumers, the biggest trends for the upcoming year will be the emergence of the edibles market and the expansion of CBD products.

  1. Which IPOs Will Take Flight?

Look for even more U.S.-based companies to offer IPOs in Canada’s markets—and vice versa.

  1. Does the U.S. Legalizing Hemp Jeopardize Canada’s Industry?

In December 2018, the U.S. Congress passed the Farm Bill, an omnibus bill that, among other things, legalized the cultivation of industrial hemp and allows for interstate commerce of hemp-based products for the first time in decades. Though this brings competition to hemp production in North America for the first time, Canada has decades of research and growing experience under its belt already.

  1. How Does Legal Weed Play Out on the International Stage?

As the second country to legalize recreational cannabis-use, Canadians are reveling in their newfound freedom. But it’s unclear how cannabis use will affect international relations.

For better or worse, 2019 will be a telling year for the Canadian cannabis market. Let me know what you think’s going to happen on Twitter (@SocialMktgFella).

Disclaimer: I have no financial interest or positions in the aforementioned companies. This information is for educational purposes and does not constitute financial and/or legal advice.

Andre Bourque (@SocialMktgFella) is a cannabis industry media influencer, brand executive and advisor, blockchain marketer, and cannabis columnist. He specializes in cannabis industry partnerships, distribution, and funding. Andre is the managing director of the cannabis div…MORE

Andre is a cannabis connector and the VP of Bus. Dev. for Verdantis Advisors, a full-service consulting agency.

Source: https://www.forbes.com/sites/andrebourque/2019/01/08/canadas-cannabis-laws-by-province-and-5-burning-questions-for-2019/#1548c5dd4eb3

$APPB Applied Biosciences Withdraws Equity Offering after Passing of Farm Bill $HTIM

Posted by AGORACOM at 8:54 AM on Thursday, January 3rd, 2019
  • Will not sell any securities under the Common Stock Purchase Agreement related to the Registration Statement.
  • December 20, 2018, President Trump signed the US Farm Bill into law
  • The new law defines hemp as an agricultural product
  • Removes hemp from the federal list of controlled substances and removes any federal regulations preventing farmers from growing and selling hemp as an agricultural commodity.

LOS ANGELES, Jan. 03, 2019 — Applied BioSciences Corp. (OTCQB: APPB), a diversified cannabinoid therapeutics company focused on the medical, bioceutical and pet health industries, announced that it has withdrawn its Registration Statement filed on December 3, 2018 and will not sell any securities under the Common Stock Purchase Agreement related to the Registration Statement.

On December 20, 2018, President Trump signed the US Farm Bill into law. The new law defines hemp as an agricultural product for the first time in 50 years and allows American farmers to plant and harvest hemp. This will allow farmers and researchers of hemp to receive the same benefits as farmers and researchers of other crops, including the ability to apply for insurance and federal grants.

The Hemp Farming Act of 2018 inclusion in the final version of the Farm Bill is a major victory for hemp CBD companies like Applied BioSciences, as it adds provisions to remove hemp from the federal list of controlled substances and removes any federal regulations preventing farmers from growing and selling hemp as an agricultural commodity. The language provides the entire supply chain with certainty and enables businesses of all sizes and types to source hemp for food, building materials and textiles from U.S. crops.

According to the Hemp Business Journal, in 2017, U.S. hemp sales reached $820 million with hemp CBD and hemp food products making up $327 million of the total and projections see U.S. CBD sales reaching $2.1 billion by 2020, even before the passage of the 2018 Farm Bill.

“The Farming Act provides much needed certainty to the hemp community and businesses that will allow them to provide products that consumer need and want. At Applied BioSciences, we strive to be a socially responsible company and invest in industries that make a positive impact, such as the CBD industry. Applied BioSciences has achieved that by diversifying ourselves amongst different CBD and hemp products, ranging from creams and oils to capsules and vapes.” stated, JJ Southard, Treasurer.

“The regulatory backdrop has changed significantly since we started the company, almost three years ago. Applied BioSciences has strived to be a cutting-edge organization and our experience in the space is a competitive advantage. With our current portfolio of brands and investments we believe there are multiple financing and strategic alternatives to generate shareholder value which are in the best interest of the company and our investors.” stated Chris Bridges President.

Applied BioSciences products are USDA NOP certified organic, non-GMO, vegan, paleo, gluten-free, sugar-free and THC-free. The products are formulated with organic 99%+ pure cannabidiol along with our proprietary blend of certified organic botanicals, herbals and essential oils to further optimize bioavailability.

About Applied BioSciences Corp.
Applied BioSciences Corp. (www.appliedbiocorp.com), is a diversified company focused on multiple areas of the medical, bioceutical and pet health industry. As a leading company in the CBD and Pet health space, the company is currently shipping to the majority of US states as well as to 5 International countries. The company is focused on select investment, consumer brands, and partnership opportunities in the recreational, health and wellness, nutraceutical, and media industries.

The company has several strategic partnerships and investments currently in place and is actively pursuing additional partnerships and strategic growth opportunities.

Contact
Email: [email protected] or [email protected]

To be added to the Applied BioSciences email distribution list, please email [email protected] with APPB in the subject line.

Official Website:www.appliedbiocorp.com
Brands:
www.remedishop.com 
www.herbalpet.com
www.canagel.com

Follow us:
Facebook @remedicbd & @HerbalPetMeds
Instagram @remedishop & @herbal_pet
Twitter @remedishop & @herbal_pet

Marijuana Company of America $MCOA Announces Filing of Registration Statement on Form S-1 to Receive up to $10M to Fund Expansion $AERO $CBDS $CGRW $APH.ca $GBLX

Posted by AGORACOM-JC at 10:16 AM on Thursday, December 27th, 2018
15233 mcoa
  • Filed a Form S-1 Registration Statement with the U.S. Securities and Exchange Commission (SEC)
  • The Company’s registration statement included a prospectus pertaining to the resale of up to 500,000,000 shares of its Common Shares, issuable to K&J Funds, LLC, a selling stockholder, pursuant to a “put right”
  • Agreement permits the Company to “put” up to ten million dollars ($10,000,000) in shares of its common stock to K&J over a period of up to thirty-six months or until $10,000,000 of such shares have been “put.”

ESCONDIDO, Calif., Dec. 27, 2018 – MARIJUANA COMPANY OF AMERICA INC. (“MCOA” or the “Company”) (OTC: MCOA), an innovative hemp and cannabis corporation, is very pleased to announce that it has filed a Form S-1 Registration Statement with the U.S. Securities and Exchange Commission (SEC). This is an important step in helping the Company to raise the necessary capital to fund its projects and expand its operations in 2019.

The Company’s registration statement included a prospectus pertaining to the resale of up to 500,000,000 shares of its Common Shares, issuable to K&J Funds, LLC (“K&J”), a selling stockholder, pursuant to a “put right” under an investment agreement (the “Investment Agreement”), dated December 20, 2018, that the Company entered into with K&J. The Investment Agreement permits the Company to “put” up to ten million dollars ($10,000,000) in shares of its common stock to K&J over a period of up to thirty-six months or until $10,000,000 of such shares have been “put.”

The total amount of shares of common stock that can be sold in the prospectus would constitute approximately 20.08% of the Company’s issued and outstanding common stock, assuming that the selling security holder will sell all of the shares offered for sale.

Don Steinberg, CEO stated: “We are extremely excited to have K&J as our financial partner for MCOA. They understand the history of the Company, our clear vision for the future and the enormous market within our reach, as reflected by this substantial commitment. This funding will give us the capital needed to expand our hempSMART brand into Europe and Asia in 2019 and prepare for our continued expansion into the hemp industry as a grower and processor in California and other areas.”

“We are happy that we are moving away from relying on convertible debt financing with variably priced conversion terms that are less favorable to our shareholders to equity financing. This will show the strength of our market capitalization and help to build a stronger balance sheet as we continue to execute our aggressive growth plans for 2019. I believe our shareholders will begin to fully appreciate our long-term strategy as we continue to realize an increase in revenue from our significant investments over the last couple of years”, said the Company’s CFO, Jesus Quintero.

This is the culmination of several steps including the filing of Form 10, filing all SEC quarterly and annual filings timely, completing several financial statement audits by a PCAOB registered firm, appointing independent directors and uplisting to the OTCQB. The Company is executing its business plan and will continue to do so with its operational initiatives in 2019 with the necessary capital in place.

A registration statement relating to these securities has been filed with the Securities and Exchange Commission but has not yet become effective. The registration statement is contingent upon it being made effective after review by the SEC. This press release is not an offer for the sale of securities in the United States or in any other jurisdiction where such offer is prohibited, and such securities may not be offered or sold in the United States absent an SEC effective registration or an exemption from registration under the United States Securities Act of 1933, as amended.

About Marijuana Company of America, Inc.
MCOA is a corporation which participates in: (1) product research and development of legal hemp-based consumer products under the brand name “hempSMART™â€, that targets general health and well-being; (2) an affiliate marketing program to promote and sell its legal hemp-based consumer products containing CBD; (3) leasing of real property to separate business entities engaged in the growth and sale of cannabis in those states and jurisdictions where cannabis has been legalized and properly regulated for medicinal and recreations use; and, (4) the expansion of its business into ancillary areas of the legalized cannabis and hemp industry, as the legalized markets and opportunities in this segment mature and develop.

About Our hempSMART Products Containing CBD
The United States Food and Drug Administration (FDA) has not recognized CBD as a safe and effective drug for any indication. Our products containing CBD derived from industrial hemp are not marketed or sold based upon claims that their use is safe and effective treatment for any medical condition as drugs or dietary supplements subject to the FDA’s jurisdiction.

Forward Looking Statements
This news release contains “forward-looking statements” which are not purely historical and may include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, the development, costs and results of new business opportunities and words such as “anticipate”, “seek”, intend”, “believe”, “estimate”, “expect”, “project”, “plan”, or similar phrases may be deemed “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new projects, the future U.S. and global economies, the impact of competition, and the Company’s reliance on existing regulations regarding the use and development of cannabis-based products. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-12G, our quarterly reports on Form 10-Q and other periodic reports filed from time-to-time with the Securities and Exchange Commission. For more information, please visit www.sec.gov.

For more information, please visit the Company’s websites at:

MarijuanaCompanyofAmerica.com
hempSMART.com
NetworkNewsWires/MCOA

Corporate Communications Contact:
NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
[email protected]

NORTHBUD $NBUD.ca Amends Licence Application to Add 500K SQ. FT. of Outdoor Cultivation Area and Provides a Corporate Update $ACB $WEED.ca $HIP.ca

Posted by AGORACOM-JC at 8:26 AM on Thursday, December 20th, 2018

  • Announced the amendment of its license application to add 500K SQ. FT. of outdoor cultivation area and provides shareholders with a corporate update on the progress of the corporation and status on its various activities.
  • Construction of NORTHBUD’s cultivation facility is progressing on schedule and on budget. The building is soon to be completely enclosed and ready for the next phase in construction.

TORONTO, Dec. 20, 2018 – North Bud Farms Inc. (CSE: NBUD) (“NORTHBUD” or the “Company”) announced the amendment of its licence application to add 500K SQ. FT. of outdoor cultivation area and provides shareholders with a corporate update on the progress of the corporation and status on its various activities.

Construction of our Cannabis Production Facility in Low, Quebec: 

The construction of NORTHBUD’s cultivation facility is progressing on schedule and on budget. The building is soon to be completely enclosed and ready for the next phase in construction. Please see our website www.northbud.com/blog for videos, photos and ongoing updates.

Request for Outdoor Cultivation License:

NORTHBUD is pursuing a standard cultivation licence under The Cannabis Act after acquiring a confirmation of readiness stage ACMPR licence application in early 2018.

The NORTHBUD production facility is located on a 95-acre parcel of farmland in rural Quebec. Under the new regulations, licenced producers can cultivate outdoors. In collaboration with Cannabis Compliance Inc. NORTHBUD will be amending its application to include a 1000 x 500ft outdoor cultivation area.  We anticipate this outdoor production footprint to be operational in the spring of 2020 pending the required approvals by Health Canada. NORTHBUD expects to begin implementation of the required infrastructure in Q2 2019 after completion of our 25k sq. ft. indoor production facility that is currently under construction.

Implementation of this additional low-cost production footprint will provide NORTHBUD a unique platform to cultivate both premium quality dried flower as well as low cost commodity grade organic biomass to be transformed into food and pharma grade inputs. This will position NORTHBUD to capitalize on the highest margin market segments.

As the consumer market develops, we believe our diverse centralized infrastructure will provide NORTHBUD a solid, low cost, high quality cannabis supply, which will serve as the core of our products and brand moving forward.

The Gatineau valley has traditionally been a fertile area for outdoor cannabis cultivation with a growing season that typically occurs between mid June and early October. NORTHBUD will be engaging local legacy cultivators to acquire genetics with a track record of success in this particular climate. Our outdoor cultivation will follow international GAP (good agricultural practices) with the drying, trimming and packaging to be done in accordance with GMP standards inside our state-of-the-art custom designed cultivation facility.

About North Bud Farms Inc.
North Bud Farms Inc., through its wholly owned subsidiary GrowPros MMP Inc. which was acquired in February 2018, is pursuing a licence under The Cannabis Act.  North Bud Farms Inc. is constructing a state-of-the-art purpose-built cannabis production facility located on 95 acres of Agricultural Land in Low, Quebec. North Bud Farms Inc. will be focused on Pharmaceutical and Food Grade cannabinoid production in preparation for the legalization of edibles and ingestible products scheduled for October 2019.

For more information visit: www.northbud.com

Neither the Canadian Securities Exchange (the “CSE”) nor its Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.

Forward-looking statements
Certain statements included in this press release constitute forward-looking information or statements (collectively, “forward-looking statements”), including those identified by the expressions “anticipate”, “believe”, “plan”, “estimate”, “expect”, “intend”, “may”, “should” and similar expressions to the extent they relate to the Company or its management. The forward-looking statements are not historical facts but reflect current expectations regarding future results or events. This press release contains forward- looking statements. These forward-looking statements are based on current expectations and various estimates, factors and assumptions and involve known and unknown risks, uncertainties and other factors. Such risks and uncertainties include, among others, the risk factors included in North Bud Farms Inc.’s final long form prospectus dated August 21, 2018 which is available under the issuer’s SEDAR profile at www.sedar.com

FOR ADDITIONAL INFORMATION, PLEASE CONTACT:
North Bud Farms Inc.
Edward Miller 
VP, IR & Communications
Office: (855) 628-3420 ext. 3
[email protected]

CLIENT FEATURE: North Bud Farms $NBUD.ca sustainable low cost, high quality cannabinoid production and procurement $ACB $WEED.ca $HIP.ca

Posted by AGORACOM-JC at 11:10 AM on Thursday, December 13th, 2018
NBUD:CSE

WHY NORTHBUD FARMS?

  • Canadian regulatory door for CIP (Cannabinoid Infused Products) is opening in 2019
    As shown in other legal jurisdictions (Colorado, Washington, Nevada, California)
  • Infused products sector has become the highest margin segment of the industry
  • Positioned to be a raw input producer for this space
  • Currently working with multiple food, beverage and science companies to provide safe standardized cannabinoid infused raw inputs for large scale GMP manufacturing of products
  • Announced Creation of “1017” Distribution and Signing of a LOI to Acquire Janey’s Cannabis Line

 NORTHBUD Construction Update, Everything is on schedule!

FULL DISCLOSURE: North Bud Farms is an advertising client of AGORA Internet Relations Corp.